U Selim

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger et al. · Annals of Oncology · 2014 · 307 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Abstract GS3-01: A prospective randomized multi-center phase-III trial of additional 2 versus additional 5 years of anastrozole after initial 5 years of adjuvant endocrine therapy – results from 3,484 postmenopausal women in the ABCSG-16 trial

Michael Gnant, G. Steger, Richard Greil et al. · Cancer Research · 2018 · 37 citations

Medicine, Oncology, Pharmacotherapy +17

Efficacy of tamoxifen±aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial

Georg Pfeiler, Herbert Stöger, Peter Dubsky et al. · British Journal of Cancer · 2013 · 26 citations · Full text

Medicine, Oncology, Pharmacology +15

Association of GB virus C (GBV-C)/hepatitis G virus (HGV) with haematological diseases of different malignant potential

Borislava G. Pavlova, R. Heinz, U Selim et al. · Journal of Medical Virology · 1999 · 22 citations

Medicine, Hematology, Infectious Diseases +13